PRINCETON, N.J., July 8, 2019 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today the appointment of Ms. Diane L. Parks

CAMBRIDGE, Mass., July 8, 2019 /PRNewswire/ -- EIP Pharma, Inc. a CNS-focused therapeutics company, today announced that it has expanded its leadership team with the appointment of Noel Donnelly as CFO. Mr. Donnelly joins EIP Pharma from Takeda Pharmaceuticals where he led a group focused on strategy and operations.

ZURICH, Switzerland, July 8, 2019 /PRNewswire/ -- Bruker today announced that it has acquired PMOD Technologies LLC, a highly respected provider of research-use-only software for preclinical and molecular imaging, with a focus on molecular quantification and pharmacokinetic modeling. The PMOD software is wi

LEEDS, England, July 8, 2019 /PRNewswire/ -- 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announces an update on its lead Live Biotherapeutic candidate for asthma, MRx-4DP0004. A multicentre Phase I/II double-blind, placebo-controlled study of MRx-4DP0004 in patients with poorly controlled asthma has no

TEL AVIV, Israel and ST. LOUIS, Missouri, July 8, 2019 /PRNewswire/ -- As the two organizations move closer to the commencement of the clinical trial to determine the safety and tolerability of the Apograft technology for bone marrow transplantations, Cellect Biotechnology Ltd. (Nasdaq: APOP), and Washington

TORRANCE, Calif., July 8, 2019 /PRNewswire/ -- Emmaus Life Sciences, Inc. ("Emmaus"), a leader in sickle cell disease treatment, announced today the screening of the first patient for the company's Pilot/Phase 1 study on the treatment of diverticulosis with pharmaceutical-grade L-glutamine ("PGLG"). The study will utilize the same PGLG oral powder used in End

NASHVILLE, Tenn., July 8, 2019 /PRNewswire/ -- Verdi Oncology, Inc., an oncology practice and clinical research management company, announced today it has partnered with Nashville Oncology Associates PC (NOA). The new partnership marks Verdi's entry into the state of Tennessee. Verdi focuses on partnering with community oncolo

PHILADELPHIA, July 8, 2019 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into a future exclusive supply and distribution agreement for the approved Levothyroxine Sodium Tablets USP of Cediprof, Inc., a wholly owned subsidiary of privately held Neolpharma Pharmaceutical Group. 

NEW YORK, July 8, 2019 /PRNewswire/ -- Health Enterprise Partners ("HEP"), a healthcare private equity firm, is pleased to announce the promotion of Elizabeth Colonna to Vice President and the hiring of Jessie Laurash as Senior Associate. 

LAVAL, QC, July 8, 2019 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ: NEPT) (TSX: NEPT) announced today the appointment of Michael Cammarata, a successful entrepreneur and innovator in the wellness industry, as its Chief Executive Officer and Member of the Board of Directors effective today,